BioRexis (acquired by Pfizer) develops protein and peptide drugs with superior half-life and pharmacokinetic profiles. The company’s protein engineering technology uses a natural variant of the human blood serum protein transferrin as a carrier protein and as a scaffold for the effective delivery of proteins and peptides.
HTH Worldwide is the leading provider of health insurance
to international students attending U.S. universities and an
innovator in online healthcare information, medical assistance
and insurance services for travelers around the globe.
Immunicon (IMMC, NASDAQ) has developed a revolutionary
diagnostic platform based on immuno-magnetic selection and
fluorescent characterization of rare cells in blood. The company’s
initial products diagnose and monitor cancer.
